Clinical Trial Update: A Study of DEG6498 in Participants With Solid Tumors [Phase 1]

View source ↗

Summary

This document reports an update on a Phase 1 study of the investigational cancer drug DEG6498 in participants with solid tumors, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DEG6498

Snippet

Sponsor: Degron Therapeutics Co. | Conditions: Malignant Neoplasms | Phase 1 | Status: RECRUITING